Navigation Links
Pros, cons of drug proven to prevent prostate cancer should be considered, researchers recommend
Date:1/20/2008

DALLAS Jan. 21, 2008 Findings by UT Southwestern Medical Center researchers encourage men to weigh both the potential benefits and side effects of the drug finasteride before taking it to prevent prostate cancer.

In todays online issue of Cancer, UT Southwestern doctors analyzed data gathered by the National Cancer Institutes Prostate Cancer Prevention Trial, or PCPT. The trial, which began in October 1993, was designed to test whether finasteride could prevent prostate cancer in men 55 years of age and older. It was stopped early in June 2003 when an analysis showed that finasteride reduced the risk of developing prostate cancer by 25 percent.

UT Southwesterns analysis of the PCPT data indicates that cost effectiveness and quality of life issues associated with taking the drug are not clear cut, said Dr. Yair Lotan, assistant professor of urology and the Cancer studys senior author. The PCPT data show that in addition to preventing prostate cancer, finasteride also reduces urinary-tract symptoms associated with benign prostatic hyperplasia. It also decreased sexual desire and caused impotence in 5 percent of the trial participants. Some PCPT participants who did develop prostate cancer also had high-grade tumors, although there is ongoing debate whether this result might have been due to sampling bias.

Finasteride is currently the only drug that has been shown to prevent prostate cancer in a large randomized trial but is used for this purpose in very few men, Dr. Lotan said. A large number of patients are currently taking over-the-counter supplements to prevent prostate cancer, even though there is no scientific evidence to support these products claims. Its important for patients to be aware of this scientific trial and to ask their doctors if finasteride could benefit them.

In light of all these pros and cons, Dr. Lotan said physicians and patients need to work together closely to weigh how finas
'/>"/>

Contact: Erin Prather Stafford
erin.pratherstafford@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. FDA Hears Pros, Cons of Pharmacist-to-Patient Drug Sales
2. Many Osteoporosis Medications Prevent Fractures, But None Is Proven Best
3. New Booklet Reveals 12 Proven Methods for Stopping MRSA from Infecting Your Feet and Your Familys Feet
4. Gildas Club Worldwide is a Proven Partner in Quality Cancer Care
5. Infliximab scheduled treatment has proven to be an effective strategy in IBD patients
6. Smoked cannabis proven effective in treating neuropathic pain
7. Benefit of exenatide has not yet been proven
8. Proven Nutrition Provides Energy and Hope to Cancer Fighters
9. Proven Terumo Coronary Guidewire Technology Is Now Available in the United States
10. European Summit on Cardiovascular Disease Prevention
11. One-third of stunting and a quarter of deaths among under 3s in poor countries could be prevented
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Pros, cons of drug proven to prevent prostate cancer should be considered, researchers recommend
(Date:9/23/2014)... Dr. Connie Casad has announced that she will be relocating ... 12200 Park Central Drive, Suite 200, Dallas, Texas 75251 on ... Aesthetics, Optimal Health and Wellness, her gynecology practice and concierge ... said, “The patients’ comfort and satisfaction are our primary goal. ... always feel like their needs are valued and recognized by ...
(Date:9/23/2014)... rapidly developing, bringing with its advances promises of ... and treatment interventions. Genetic tests are already ... and hepatitis c virus (HPC), and emerging research ... screen for an individual,s susceptibility to addiction to ... , While there appear to be many benefits ...
(Date:9/23/2014)... News) -- Few children who take medication for ... the rates vary six-fold across counties in the ... alone can manage symptoms for many children with ... receive behavioral therapy (psychotherapy), the Rand Corp. researchers ... than 1,500 counties across the United States that ...
(Date:9/23/2014)... Both patients and healthcare professionals believe diagnosis of ... greatly outweighs the potential disadvantages of subsequent radiologic ... according to a new study published in the ... , Diagnostic tests used for cancer screening programs ... for colorectal cancer with CT colonography, abdominal and ...
(Date:9/23/2014)... Boston, MA (PRWEB) September 23, 2014 ... announced that $50,000 investments each were made to ... the top two health ventures with business solutions to ... , SOURCE is a first-of-its-kind collaboration between The ... Investors' Circle that connects entrepreneurs with the investment ...
Breaking Medicine News(10 mins):Health News:Dr. Connie Casad Moving to New Office Location 2Health News:NYU-Mount Sinai Beth Israel study explores drug users' opinions on genetic testing 2Health News:Kids Taking ADHD Drugs Get Little Psychotherapy: Study 2Health News:Patients accept false-positives to achieve diagnostic sensitivity 2Health News:Patients accept false-positives to achieve diagnostic sensitivity 3Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 2Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 3Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 4Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 5
... talked about by only 20% of patients , , MONDAY, ... rheumatoid arthritis (RA) may be at increased risk for ... says a U.S. study that included 200 RA patients ... Betsy Sleath, of the University of North Carolina at ...
... Feb. 11 CAQH announced today,that the eligibility ... for Information Exchange (CORE) Phase I rules is ... Panel,s (HITSP) first set,of interoperability standards. These standards ... Mike Leavitt late last month., This recognition ...
... Feb. 11 The Employer Support of the ... Alliance to,its list of companies that provide extra-ordinary ... Reserves., National ESGR Executive Director Dr. Gordon ... gathering of the company,s leadership Sunday,in Westlake Village. ...
... Chesapeake Corporation,(NYSE: CSK ), a leading international ... supplier of printed pharmaceutical,leaflets in North America, today ... on Long Island, N.Y., and relocating,from its current ... "Our business has grown substantially since we moved ...
... at Childrens Hospital of Pittsburgh of UPMC have identified a ... the development of a vaccine to prevent and new therapies ... Research led by Jay K. Kolls, MD, chief of the ... identified for the first time the importance of a protein ...
... MINNEAPOLIS, Feb. 11 Uroplasty, Inc. (Amex:,UPI), ... and markets,innovative proprietary products for the treatment ... PC Neuromodulation System, its,proprietary, minimally invasive nerve ... bladder (OAB) symptoms, will be,featured in three ...
Cached Medicine News:Health News:Depression Rarely Discussed With RA Patients 2Health News:CAQH Core Rules Final Component of HITSP Interoperability Standards Formally Recognized By HHS Sec. Leavitt 2Health News:CAQH Core Rules Final Component of HITSP Interoperability Standards Formally Recognized By HHS Sec. Leavitt 3Health News:TriWest Named 'Top-Level' Employer of Guard, Reserve Troops 2Health News:Chesapeake to Expand and Relocate North American Pharmaceutical Packaging Operation 2Health News:Children's Hospital scientists identify possible target for prevention and treatment of pneumonia 2Health News:Studies on Urgent(R) PC to be Presented at the 2008 Society of Urologic Nurses and Associates Annual Symposium 2
(Date:9/23/2014)... , Sept. 23, 2014 Research ... the "Physician Office Laboratory Markets, 3rd Edition" ... This report, Physician Office Laboratory Markets is Kalorama,s ... IVD industry. Physician office laboratories are diverse in ... perform reimbursable, in-office pregnancy and glucose tests. Some ...
(Date:9/23/2014)... DUBLIN , September 23, 2014 /PRNewswire/ ... ) has announced the addition of the  ...  report to their offering.  ... injectable drug delivery market holds significant potential ... with vials and painful needles to the ...
(Date:9/23/2014)... -- SiteOne Therapeutics Inc. today announced the completion of its ... Management and Biobrit LLC, with additional investors Mission Bay ... financing positions SiteOne to advance its oral Na V ... its technology platform for long-acting local analgesics, pain diagnostics ... the financing, Lowell Sears (Sears Capital Management) ...
Breaking Medicine Technology:Physician Office Laboratory Markets, 3rd Edition 2Physician Office Laboratory Markets, 3rd Edition 3Large Volume Wearable Injectors - 2nd Edition 2Large Volume Wearable Injectors - 2nd Edition 3Large Volume Wearable Injectors - 2nd Edition 4Large Volume Wearable Injectors - 2nd Edition 5SiteOne Therapeutics Completes $1.5M Initial Round of Equity Financing, Secures $1.4M NIH Grant 2SiteOne Therapeutics Completes $1.5M Initial Round of Equity Financing, Secures $1.4M NIH Grant 3
... 3 Australian researchers have developed gene expression ... colorectal growths from non-cancerous controls. , , ... conference in Chicago, the preliminary findings are the ... Flinders University and Australian healthcare company, Clinical Genomics ...
... Day 3 And All Subsequent Study Visits - , ... Pharma Co., Ltd., (DSP) announced today that positive results from ... of patients with schizophrenia have been published in The ... placebo-controlled trial, involving 180 patients with acute schizophrenia, evaluated a ...
Cached Medicine Technology:Advance in Bowel Cancer Test Research 2Study Demonstrating Lurasidone Is Effective in Patients With Schizophrenia Published in The Journal of Clinical Psychiatry 2Study Demonstrating Lurasidone Is Effective in Patients With Schizophrenia Published in The Journal of Clinical Psychiatry 3Study Demonstrating Lurasidone Is Effective in Patients With Schizophrenia Published in The Journal of Clinical Psychiatry 4
0.5mm "K" hook. Rounded knurled handle; shaft angled 11mm from tip; overall length 120mm, in Titanium....
Lightly Curved-Blunt Tips Rounded Blades; 1mm Eye in Blades; 27mm from mid screw to tip. Matte finish; Stainless Steel, overall length 120mm...
... Perfusion Catheter is indicated for ... portion of a coronary artery ... the purpose of improving myocardial ... are also designed to provide ...
... The eSpeed C300 uses its hallmark 50 and ... techniques. New MultiPhase scan protocols and proprietary ... C300s four beam targets and two x-ray detector ... arteries and analyze myocardial perfusion and wall motion. ...
Medicine Products: